News and features

Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.

If you’re a journalist and want to find out more, you can contact our media relations team.

ICR Logo
ICR Discovery Club celebrates the second anniversary of the Centre for Cancer Drug Discovery

07/11/22

Members of the ICR’s Discovery Club gathered at The Royal Society to hear about our new five-year research strategy and to mark two years since the opening of our pioneering Centre for Cancer Drug Discovery.
Breast cancer cell
Breast cancer test could guide treatment for more aggressive subtype

31/10/22

A new breast cancer test could detect women who are less likely to respond to a standard breast cancer treatment – and could help improve treatment for these women by giving them other treatment options earlier.
DNA unwound from histone epigenetics
Landmark Nature papers unveil ‘dark matter’ shaping cancer behaviour

26/10/22

Cancers can evolve to become more aggressive without relying only on DNA mutations, two major studies published simultaneously in Nature reveal.
School student using microscope
ICR ranked amongst top UK universities for partnerships and public engagement

24/10/22

The ICR has been rated as one of the UK's top higher education institutions in three categories in the latest Knowledge Exchange Framework (KEF), a Government assessment of universities' influence on society.
stomach-cancer-katharina-von-loga_v2
Study opens route to overcoming drug resistance in stomach cancer

23/10/22

Scientists have shown how stomach cancers can dodge the effects of a promising new experimental treatment – raising the possibility of outsmarting cancer by predicting drug resistance in advance.
Rhabdomyosarcoma cells (photo courtesy of Dr Ewa Aladowicz in Professor Janet Shipley's team at the ICR)
Blood tests could offer smarter treatment for children’s cancer

20/10/22

A simple blood test could help guide the treatment of children with the cancer rhabdomyosarcoma, a new study reports.
Breast cancer cell
Triple negative breast cancer’s reliance on sperm and egg production proteins may offer new treatment pathways

12/10/22

Scientists have discovered the key role of a series of proteins in the survival of some triple negative breast cancers.
Breast cancer cells on a black background
Immune targets for chemotherapy-resistant breast cancers identified

26/09/22

Researchers perform a deep dive into the different immune markers within tumour tissue and blood samples of early breast cancer patients whose cancer failed to respond to chemotherapy given to them prior to surgery - the findings could help tailor pre-surgical treatment.
Public Engagement and launch of student exchange in India 547 x 410
World Cancer Research Day: how international collaborations benefit the global cancer research community

24/09/22

The Centre for Global Oncology will help to to connect and develop cancer scientists around the world.
carcinoma of salivary gland
Genetically modified herpes virus delivers one-two punch against advanced cancers

22/09/22

A new genetically engineered virus has delivered a one-two punch against advanced cancers in initial findings from a phase I trial.
Oral squamous cancer cell (white) being attacked by two cytotoxic T cells (red)
Deliberately damaging DNA could boost the effectiveness of immunotherapy in kidney cancer

20/09/22

DNA damage is one of the foundational causes of cancer. But researchers have now found that deliberately causing DNA damage – by delivering additional treatments like radiotherapy – could improve the effectiveness of immunotherapy for some people with kidney cancer.
Union flag flying at half-mast
ICR statement on the death of Her Majesty The Queen

08/09/22

It is with deep sadness that The Institute of Cancer Research, London, marks the death of Her Majesty The Queen.

Make a donation today

A monthly gift can help support our research over several years, so it has the maximum possible benefit for people with cancer.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

With your generous support, we can continue making more discoveries, finding more cures, and saving more lives.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Our research centres & divisions

Through our close partnerships with The Royal Marsden and other key UK institutions, we're leading a wide breadth of cancer research across eight divisions and more than 25 research centres and strategic initiatives.